Logo image of XTNT

XTANT MEDICAL HOLDINGS INC (XTNT) Stock Overview

NYSEARCA:XTNT - US98420P3082 - Common Stock

0.6101 USD
-0.02 (-3.47%)
Last: 9/4/2025, 5:05:00 PM

XTNT Key Statistics, Chart & Performance

Key Statistics
52 Week High0.78
52 Week Low0.33
Market Cap79.51M
Shares130.32M
Float109.89M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.04
PEN/A
Fwd PEN/A
Earnings (Next)11-10 2025-11-10/bmo
IPO06-30 2010-06-30
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Supplies


XTNT short term performance overview.The bars show the price performance of XTNT in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 20 30

XTNT long term performance overview.The bars show the price performance of XTNT in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 -10 -20 -30 -40

The current stock price of XTNT is 0.6101 USD. In the past month the price increased by 6.62%. In the past year, price increased by 7.96%.

XTANT MEDICAL HOLDINGS INC / XTNT Daily stock chart

XTNT Competitors/Peers

The largest stocks on the US markets in the "Health Care Supplies" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ALC ALCON INC 26.13 39.43B
COO COOPER COS INC/THE 16.92 13.57B
SOLV SOLVENTUM CORP 11.9 12.55B
ALGN ALIGN TECHNOLOGY INC 14.31 9.76B
MMSI MERIT MEDICAL SYSTEMS INC 25.18 5.46B
BLCO BAUSCH + LOMB CORP 34.74 5.16B
LNTH LANTHEUS HOLDINGS INC 8.42 3.66B
ICUI ICU MEDICAL INC 16.71 3.10B
XRAY DENTSPLY SIRONA INC 8.38 2.86B
HAE HAEMONETICS CORP/MASS 11.63 2.61B
UFPT UFP TECHNOLOGIES INC 24.2 1.61B
STAA STAAR SURGICAL CO N/A 1.37B

About XTNT

Company Profile

XTNT logo image Xtant Medical Holdings, Inc. designs, and develops orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. The company is headquartered in Belgrade Montana, Montana and currently employs 217 full-time employees. The company went IPO on 2010-06-30. The firm is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoVive, OsteoFactor, line of 3Demin products, as well as other allografts. The company offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical products, Thoracolumbar products, Sacroiliac Joint products, Interbody products and Interlaminar Stabilization products.

Company Info

XTANT MEDICAL HOLDINGS INC

664 Cruiser Lane

Belgrade Montana MONTANA 59714 US

CEO: Sean E. Browne

Employees: 225

XTNT Company Website

XTNT Investor Relations

Phone: 14063880480

XTANT MEDICAL HOLDINGS INC / XTNT FAQ

What is the stock price of XTANT MEDICAL HOLDINGS INC today?

The current stock price of XTNT is 0.6101 USD. The price decreased by -3.47% in the last trading session.


What is the ticker symbol for XTANT MEDICAL HOLDINGS INC stock?

The exchange symbol of XTANT MEDICAL HOLDINGS INC is XTNT and it is listed on the NYSE Arca exchange.


On which exchange is XTNT stock listed?

XTNT stock is listed on the NYSE Arca exchange.


What is the price forecast or stock price prediction for XTANT MEDICAL HOLDINGS INC stock?

8 analysts have analysed XTNT and the average price target is 1.79 USD. This implies a price increase of 192.57% is expected in the next year compared to the current price of 0.6101. Check the XTANT MEDICAL HOLDINGS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is XTANT MEDICAL HOLDINGS INC worth?

XTANT MEDICAL HOLDINGS INC (XTNT) has a market capitalization of 79.51M USD. This makes XTNT a Micro Cap stock.


How many employees does XTANT MEDICAL HOLDINGS INC have?

XTANT MEDICAL HOLDINGS INC (XTNT) currently has 225 employees.


What are the support and resistance levels for XTANT MEDICAL HOLDINGS INC (XTNT) stock?

XTANT MEDICAL HOLDINGS INC (XTNT) has a support level at 0.61 and a resistance level at 0.63. Check the full technical report for a detailed analysis of XTNT support and resistance levels.


Is XTANT MEDICAL HOLDINGS INC (XTNT) expected to grow?

The Revenue of XTANT MEDICAL HOLDINGS INC (XTNT) is expected to grow by 10.6% in the next year. Check the estimates tab for more information on the XTNT EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy XTANT MEDICAL HOLDINGS INC (XTNT) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does XTANT MEDICAL HOLDINGS INC (XTNT) stock pay dividends?

XTNT does not pay a dividend.


When does XTANT MEDICAL HOLDINGS INC (XTNT) report earnings?

XTANT MEDICAL HOLDINGS INC (XTNT) will report earnings on 2025-11-10, before the market open.


What is the Price/Earnings (PE) ratio of XTANT MEDICAL HOLDINGS INC (XTNT)?

XTANT MEDICAL HOLDINGS INC (XTNT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.04).


What is the Short Interest ratio of XTANT MEDICAL HOLDINGS INC (XTNT) stock?

The outstanding short interest for XTANT MEDICAL HOLDINGS INC (XTNT) is 0.03% of its float. Check the ownership tab for more information on the XTNT short interest.


XTNT Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to XTNT. When comparing the yearly performance of all stocks, XTNT is a bad performer in the overall market: 74.04% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

XTNT Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to XTNT. Both the profitability and financial health of XTNT have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

XTNT Financial Highlights

Over the last trailing twelve months XTNT reported a non-GAAP Earnings per Share(EPS) of -0.04. The EPS decreased by -100% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -12.51%
ROE -27.33%
Debt/Equity 0.51
Chartmill High Growth Momentum
EPS Q2Q%166.67%
Sales Q2Q%18.26%
EPS 1Y (TTM)-100%
Revenue 1Y (TTM)28.44%

XTNT Forecast & Estimates

8 analysts have analysed XTNT and the average price target is 1.79 USD. This implies a price increase of 192.57% is expected in the next year compared to the current price of 0.6101.

For the next year, analysts expect an EPS growth of 83% and a revenue growth 10.6% for XTNT


Analysts
Analysts85
Price Target1.79 (193.39%)
EPS Next Y83%
Revenue Next Year10.6%

XTNT Ownership

Ownership
Inst Owners57.58%
Ins Owners14.69%
Short Float %0.03%
Short Ratio0.48